Skip to main content
See details

Reimbursement summary for angioplasty of arteries of lower extremities

This post presents an extract from our reimbursement analysis for angioplasty of arteries lower extremities using plain and drug-coated balloons (DCBs) for peripheral artery disease in England, France and Germany. Plain balloon angioplasty is reimbursement via DRG solely and DCBs are reimbursement via combination of DRG and add-on reimbursement.
See details

Revision of the Danish National Clinical Guideline for Treatment of Brain Metastasis

In 2014 the Danish National Board of Health (Sundhedsstyrelsen) has published the National Clinical Guideline for the Treatment of Brain Metastases (full text of the guideline can be found here).

The guideline focuses on which oncology and neurosurgical treatments are relevant for the patient groups, as well as on patient-specific factors that determine the choice of treatment. An aggressive treatment strategy like surgery and radiation therapy may seem obvious. Conversely, these treatments are associated with the risk of complications, and therefore it is important that patients are carefully selected for the treatment they are most benefited from.

The background for updating the National Clinical Guideline for Treatment of Brain Metastases is that local treatment (stereotactic radiation therapy) has gained more space in the treatment of brain metastases since 2014 and that the working group estimated that new evidence-based knowledge has been obtained in this area.

Therefore, the National Board of Health today sends a new updated National Clinical Guideline in consultation. The purpose of the guideline is to provide knowledge-based national recommendations for the treatment of patients with brain metastases.

The Danish National Board of Health has launched a new updated National Clinical Guideline for consultation. The guideline is in consultation until February 16, 2018, via the consultation portal.

See full details in Danish here.

Subscribe to our newsletter delivered every second week not to miss important reimbursement information.